CONSUN PHARMA (01681): Lee Cheuk Kwong appointed as Independent Non-executive Director.
Kangzin Pharmaceutical (01681) announced that, effective from February 24, 2025, Ms. Chen Yujun has resigned as an independent...
CONSUN PHARMA (01681) announced that, effective from February 24, 2025: Ms. Chen Yujun has resigned as an independent non-executive director and will no longer serve as chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Li Zhuoguang has been appointed as an independent non-executive director, chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Fang Peicheng will no longer concurrently serve as the Chief Financial Officer; Ms. Chen Yujun has been appointed as the Chief Financial Officer.
Related Articles
CHINA RISUN GP (01907) operates steadily, attracting continued attention from mainland investors.
HK Stock Market Move | ITC PROPERTIES (00199) resumed trading and surged over 70%. The company plans to issue rights shares at a discount to Ray Kai Group in order to integrate into the Web3.0 ecosystem and achieve business transformation.
Key projects have entered a period of intensive implementation, Zhaojin Mining's development acceleration plan is fully speeding up.
CHINA RISUN GP (01907) operates steadily, attracting continued attention from mainland investors.
HK Stock Market Move | ITC PROPERTIES (00199) resumed trading and surged over 70%. The company plans to issue rights shares at a discount to Ray Kai Group in order to integrate into the Web3.0 ecosystem and achieve business transformation.
Key projects have entered a period of intensive implementation, Zhaojin Mining's development acceleration plan is fully speeding up.
